ACLY and neoplasm: Georgia Hatzivassiliou et al. demonstrated that the knocking down of ACLY, as a key enzyme integrating glucose and lipid metabolism, limited the growth and survival of aerobic glycolytic tumor cells in vitro and reduced tumor development in vivo [107].